# Polyvinyl Alcohol Embolization Microspheres

> **NCT05770635** · NA · UNKNOWN · sponsor: **Shanghai Huihe Medical Technology Co., Ltd** · enrollment: 224 (estimated)

## Conditions studied

- Primary Liver Cancer

## Interventions

- **DEVICE:** Embosphere and chemotherapy drug
- **DEVICE:** Polyvinyl alcohol embolization microspheres (Huihe Medical) and chemotherapy drug

## Key facts

- **NCT ID:** NCT05770635
- **Lead sponsor:** Shanghai Huihe Medical Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-28
- **Primary completion:** 2024-12-28
- **Final completion:** 2024-12-28
- **Target enrollment:** 224 (ESTIMATED)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05770635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05770635, "Polyvinyl Alcohol Embolization Microspheres". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05770635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*